| Grab Sources And More: INBS Website. INBS Presentation. -----
And based on multiple potential catalysts mentioned above, (Nasdaq: INBS) has quickly risen the ranks to the top spot on my watchlist. Check them out:
#1. INBS Potential Catalyst - A Low Float Could Create Heightened Volatility In A Flash.
According to info from the Yahoo Finance website, INBS has a fairly low float.
In fact, the website reports this profile to have approx. 6.19Mn shares in its float.
Why is that important? It's important on one crucial level. Volatility potential.
If the company provides company news in the mid-way point of 2025, could it, with the help of a low float, help create a breakout spark? -----
#2. INBS Potential Catalyst - A Multitude Of Triggered Technicals Could Generate Breakout Buzz!
On Tuesday at 4:00PM EST, Barchart was reporting several triggered technical indicators across the short, medium, and long term for INBS.
Here's their list (as of 4:00PM EST Tuesday):
Short Term Indicators
- 20 Day Moving Average
- 20 - 50 Day MA Crossover
- 20 - 100 Day MA Crossover
- 20 - 200 Day MA Crossover
Medium Term Indicators
- 50 Day Moving Average
- 50 - 100 Day MA Crossover
- 50 - 150 Day MA Crossover
- 50 - 200 Day MA Crossover
Long Term Indicators
- 100 Day Moving Average
- 150 Day Moving Average
- 200 Day Moving Average
- 100 - 200 Day MA Crossover
The website also shares its all-important "Trend Seeker" composite indicator is triggered as well.
Make sure to watch these technical indicators closely moving forward. -----
#3. INBS Potential Catalyst - An Analyst $12 Target Suggests Triple-Digit Potential Upside.
From its closing valuation on Tuesday, that $12 target is suggesting INBS to have over 425% potential upside.
This price target reflects strong analyst confidence in Intelligent Bio Solutions Inc.'s future performance, driven by major advances in FDA regulatory pathways for its drug screening system and a strategic expansion into new markets including key partnerships in Europe and initiatives for a U.S. launch.
Ladenburg Thalmann's established reputation as a Wall Street firm adds further weight to the target and underscores the attention INBS could receive as an undervalued profile. -----
#4. INBS Potential Catalyst - A New Global Distribution Agreement With A Long Standing Partner Could Prove Extremely Fruitful.
Intelligent Bio Solutions Accelerates Global Growth with SmarTest® Patch Agreement, Reinforces U.S. Expansion Path as FDA Approval Remains a Strategic Priority
NEW YORK, July 16, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), ..., today announced a new global distribution agreement with SMARTOX®, a Texas-based leader in drug and alcohol screening services, to bring its SmarTest Patch drug detection product to international markets outside of the United States (“U.S”) and Canada. This partnership builds on the long-standing relationship between INBS and SMARTOX, the U.S. distributor of INBS’s Intelligent Fingerprinting Drug Testing Solution in the Forensic Use Only market.
...
Read the full article here. -----
#5. INBS Potential Catalyst - Company Adds Next-Gen Wearable To Product Offering (SmarTest® Patch).
Intelligent Bio Solutions Adds Next-Gen Wearable for Extended Drug Detection to Product Offering, Strengthening Leadership in Non-Invasive Testing
NEW YORK, July 15, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), ..., today announced the addition of the SmarTest® Patch to its portfolio of non-invasive drug testing solutions. The SmarTest Patch is an innovative wearable device, developed by SMARTOX®, that enables continuous drug detection through sweat over a 7 to 10-day period. The SmarTest Patch complements the Company's flagship product, the Intelligent Fingerprinting Drug Testing Solution, strengthening its product portfolio of sweat-based, non-invasive testing technologies.
...
Read the full article here. -----
(Nasdaq: INBS) Recap - 5 Potential Catalysts Lead The Way
#1. A Low Float Could Create Heightened Volatility In A Flash.
#2. A Multitude Of Triggered Technicals Could Generate Breakout Buzz!
#3. An Analyst $12 Target Suggests Triple-Digit Potential Upside.
#4. A New Global Distribution Agreement With A Long Standing Partner Could Prove Extremely Fruitful.
#5. Company Adds Next-Gen Wearable To Product Offering (SmarTest® Patch). -----
Coverage is officially reinitiated on Intelligent Bio Solutions Inc. (Nasdaq: INBS).
I'll be in touch with updates as the week moves on. Talk again soon.
Sincerely, FierceAnalyst | Jaks Swift Editorial Writer
Sources: (1)(2)
(Always Remember The St-ock Prices Could Be Significantly Lower Now From The Dates I Provided.)
*FierceInvestor (FierceInvestor . com) is owned by SWN Media LLC, a limited liability company. Data is provided from third-party sources and FierceInvestor ("FI") is not responsible for its accuracy. Make sure to always do your own research and due diligence on any day and swing profile I bring to your attention. We do not provide personalized fin-ancial advice, are not finan-cial advisors, and our opinions are not suitable for all in-vest-ors.
Pursuant to an agreement between SWN Media LLC and TD Media LLC, SWN Media LLC has been hired for a period beginning on 07/22/2025 and ending on 07/23/2025 to publicly disseminate information about (INBS:US) via digital communications. Under this agreement, SWN Media LLC has been paid ten thousand USD ("Funds"). To date, including under the previously described agreement, SWN Media LLC has been paid twenty five thousand USD ("Funds"). These Funds were part of the funds that TD Media LLC received from a third party who did not receive the Funds directly or indirectly from the Issuer and does not own st-ock in the Issuer but the reader should assume that the clients of the third party own shares in the Issuer, which they will liquidate at or near the time you receive this communication and has the potential to hurt share prices.
Neither SWN Media LLC, TD Media LLC and their member own shares of (INBS:US).
Please see important disclosure information here: https://fierceinvestor.com/disclosure/inbs-3k8kx/#details | 
No comments:
Post a Comment